Letters Section Editor: Jody W. Zylke, MD, Senior Editor.
Author Affiliations: Division of Anesthesiology, Geneva University Hospitals, Geneva, Switzerland (email@example.com).
To the Editor: Dr Gallagher and colleagues1 examined the risk of bleeding associated with dexamethasone administered to children undergoing tonsillectomy. The authors concluded that dexamethasone was not associated with bleeding requiring reoperation, using a noninferiority threshold of 5%.
Gallagher et al1 applied the same threshold of 5% to all bleeding end points (any bleeding, bleeding requiring rehospitalization, reoperation due to bleeding) to indicate noninferiority. We agree that an increase of 5% in level I bleeding (any bleeding) might not necessarily be of clinical relevance. However, an increase of 5% in level III bleeding (ie, those needing a reoperation) is quite different.
Czarnetzki C, Elia N, Tramèr MR. Bleeding Risk and Dexamethasone Use in Children Undergoing Tonsillectomy. JAMA. 2013;309(5):437–438. doi:10.1001/jama.2012.113510
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: